ARCHIVES

CTEP Drafts FDA Approval Guidelines

This article is from The Cancer Letter archive.

Vol. 14 No. 10 | March 4, 1988

Download PDF Visit The Full Archive

Related Articles

Reexamine Mandates, Samuels Suggests

February 17, 1984

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

Peer Review changes Urged By NIH Team Include Appeals

April 8, 1977

NCI Cancer Studies In China Intact; Visits Delayed

July 14, 1989

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996